Petros Pharmaceuticals, Inc. (PTPI)

Petros Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.89	13.34	9.43	23.85	17.14	2.15
Cash & Short-Term Investments	3.89	13.34	9.43	23.85	17.14	2.15
Cash Growth	-78.33%	41.49%	-60.47%	39.14%	698.75%	-23.20%
Accounts Receivable	1.95	2.23	2.11	2.46	5.15	2.61
Other Receivables	-	-	-	0.61	-	1.55
Receivables	1.95	2.23	2.11	3.06	5.15	4.16
Inventory	3.05	2.79	1.82	0.52	0.76	2.2
Prepaid Expenses	0.4	1.22	0.51	1.58	1.37	1.56
Other Current Assets	1.42	0.82	0.8	1.53	1.48	2.02
Total Current Assets	10.72	20.39	14.67	30.54	25.91	12.09
Property, Plant & Equipment	0.14	0.26	0.4	0.52	0.64	0.74
Other Intangible Assets	6.83	8.97	12.24	25.29	32.16	38.81
Other Long-Term Assets	3	4.18	5.11	11.03	11.14	6.73
Total Assets	20.69	33.8	32.42	67.39	69.85	58.37
Accounts Payable	1.6	1.71	1.81	4.56	5.61	3.78
Accrued Expenses	2.98	3.23	1.32	3.5	2.96	7.92
Current Portion of Long-Term Debt	2.33	1.16	1.09	-	7.18	6.68
Current Portion of Leases	-	0.13	0.14	0.13	0.11	0.1
Other Current Liabilities	5.65	4.55	2.71	22.8	26.04	22.63
Total Current Liabilities	12.56	10.77	7.07	30.98	41.89	41.1
Long-Term Debt	4.92	6.86	8.39	-	-	7.06
Long-Term Leases	0.09	0.14	0.26	0.41	0.53	0.64
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1.43
Other Long-Term Liabilities	-	3.55	0	0.46	9.96	0.11
Total Liabilities	17.58	21.32	15.72	31.85	52.38	50.35
Common Stock	0	0	0	0	0	29.12
Additional Paid-In Capital	107.05	110.96	107.43	106.23	79.17	-
Retained Earnings	-103.93	-98.89	-90.73	-70.69	-61.7	-41.12
Total Common Equity	3.12	12.07	16.7	35.54	17.47	-12
Shareholders' Equity	3.12	12.48	16.7	35.54	17.47	8.02
Total Liabilities & Equity	20.69	33.8	32.42	67.39	69.85	58.37
Total Debt	7.34	8.28	9.88	0.53	7.81	14.48
Net Cash (Debt)	-3.45	5.06	-0.46	23.32	9.33	-12.33
Net Cash Growth	-	-	-	150.05%	-	-
Net Cash Per Share	-0.57	2.33	-0.22	21.41	17.46	-50.13
Filing Date Shares Outstanding	10.01	6.88	2.09	2.07	0.98	3.43
Total Common Shares Outstanding	10.01	2.99	2.08	2.07	0.97	3.43
Working Capital	-1.84	9.62	7.6	-0.44	-15.99	-29.02
Book Value Per Share	0.31	4.04	8.03	17.18	18.00	-3.49
Tangible Book Value	-3.71	3.1	4.46	10.25	-14.69	-50.81
Tangible Book Value Per Share	-0.37	1.04	2.14	4.96	-15.13	-14.79
Machinery	-	-	-	-	-	0.07

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q